ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1382	National Cancer Institute	Html	en	Cancer Prevention Overview (PDQ®)–Health Professional Version	General information about cancer prevention and descriptions of the concepts used in cancer-specific prevention summaries.	cancer chemopreventive effect. 0.358688 female breast cancer 0.366067 Breast Cancer Screening 0.3766 evidence 0.374057 World Cancer Research 0.371637 Australian Cancer Database. 0.371153 real-world cancer risks 0.364978 prostate cancer incidence 0.391381 cancer prevention strategies 0.427184 total cancer incidence. 0.39992 postmenopausal breast cancer 0.369903 aforementioned cancer sites 0.361157 overall cancer incidence 0.381148 cancer prevention potential 0.400219 cancer risks 0.367573 cancer causation 0.354757 Prostate Cancer Prevention 0.44176 important cancer risk 0.405276 ionizing radiation 0.400694 CT scans 0.437022 cancer prevention 0.770874 major inherited cancer 0.391979 medical ionizing radiation 0.356801 Skin Cancer Prevention 0.402533 human cancer risk 0.408538	Lung Cancer Prevention 0.507998 male breast cancer 0.364817 radiation exposure 0.351376 PDQ cancer prevention 0.470906 high-grade prostate cancer 0.364217 Colorectal Cancer Prevention 0.442204 Endometrial Cancer Prevention 0.388658 cancer progression 0.372078 specific anatomic cancer 0.400991 Breast Cancer Prevention 0.570001 Cancer Prevention Trial 0.382817 overall cancer mortality. 0.36635 breast cancer 0.600813 colon cancer risk 0.403854 cancer prevention efforts 0.388092 cancer prevention summaries 0.464026 pancreatic cancer incidence 0.379746 cancer site 0.376277 radiation 0.413856 cancer risk 0.665025 breast cancer incidence 0.435711 lung cancer incidence 0.378316 cancer 0.940616 liver cancer 0.392701	CLICK HERE
1432	National Cancer Institute	Html	en	Childhood Extracranial Germ Cell Tumors Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of childhood extracranial germ cell tumors.	high-risk malignant germ 0.382627 germ cell tumor 0.468475 testicular germ cell 0.429106 children 0.370996 nonseminomatous germ cell 0.393341 germ cell tumours 0.41986 Perlman EJ 0.354009 metastatic germ cell 0.400721 Cancer Group 0.365469 Cancer Res 0.351158 German germ cell 0.402914 ovarian malignant germ 0.383572 International Germ Cell 0.398303 childhood endodermal sinus 0.354399 malignant extracranial germ 0.38557 extragonadal germ cell 0.411876 Germ Cell Cancer 0.403131 Pediatric malignant germ 0.402466 childhood cancer 0.363851 eighty-one pediatric germ 0.390298 mediastinal germ cell 0.418591 sacrococcygeal germ cell 0.389319 pediatric germ cell 0.545311 et al. 0.455659	germ cell neoplasms 0.392505 childhood cancer mortality 0.358219 Cancer Genet Cytogenet 0.354846 extracranial germ cell 0.411151 ovarian germ cell 0.394977 United States 0.356408 poor-prognosis metastatic germ 0.37618 Germ Cell Consensus 0.387357 PUBMED Abstract 0.47974 Pediatric Oncology Group/Children 0.350706 Genes Chromosomes Cancer 0.370613 malignant germ cell 0.446287 Clin Oncol 0.410768 adolescent cancer survivors 0.362753 endodermal sinus tumors 0.380924 Schneider DT 0.373974 male germ cell 0.395998 germ cell tumors 0.95816 gonadal tumors 0.362307 primary germ cell 0.419689 cancer 0.42182 pediatric oncology group 0.391354 childhood germ cell 0.423704 germ cell cancers 0.387284	CLICK HERE
1470	National Cancer Institute	Html	en	Gestational Trophoblastic Disease Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of gestational trophoblastic disease.	hydatidiform moles 0.634979 evidence 0.648348 choriocarcinoma patients 0.633963 lung metastases 0.696902 gestational trophoblastic disease 0.762186 beta-human chorionic gonadotropin 0.712697 methotrexate 0.977049 best chemotherapeutic regimen. 0.698595 weekly serum 0.630264 long-term cure rate 0.678475 intrathecal methotrexate 0.762465 8-day regimen 0.717809 initial remission rate 0.739354 first-line regimens 0.730221 folinic acid 0.91402 complete remission rate 0.700307 cisplatin-containing regimens 0.686171 ultimate cure rates 0.711961 Cochrane systematic review 0.696497 small sample size 0.696983 dermatologic toxicity 0.625796 initial treatment 0.625308 CHAMOMA regimen 0.706394 liver metastases 0.695394	statistically significant increase 0.714425 systemic methotrexate 0.81856 multiagent chemotherapy 0.710778 EMA/CO regimen 0.689015 alternate regimens 0.70432 low-grade gastrointestinal toxicity 0.724629 brain metastases 0.929548 patients 0.70324 regimens 0.73975 worse CR rate 0.705341 initial regimen 0.733597 initial management 0.736659 salvage regimen 0.720473 empiric study. 0.630801 therapeutic CNS levels. 0.6786 Monthly follow-up 0.629157 dactinomycin group 0.711146 human chorionic gonadotropin 0.959993 gestational trophoblastic neoplasia 0.961468 statistically significant decrease 0.714076 best chemotherapy regimen 0.855235 5-day regimen 0.715118 commonly used regimen 0.784545	CLICK HERE
1486	National Cancer Institute	Html	en	Melanoma Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of melanoma.	temozolomide versus dacarbazine 0.706064 standard therapy arm 0.513108 individual treatment sections 0.538046 single-agent inhibitor 0.443006 BRAF-mutated metastatic melanoma 0.711751 Val600 BRAF-mutant melanoma 0.627182 drug targets 0.434691 clinical trial design 0.573658 Drug Administration 0.434687 primary endpoint 0.423708 DTIC 0.525789 MEK inhibitor 0.453277 rare CRs 0.424667 active moiety 0.422545 randomized trials. 0.46852 BRAF-mutant subtype 0.57943 phase III study 0.513517 important option 0.423407 phase iii trials 0.549837 oral alkylating agent 0.523779 clinical trials 0.434562 V600 mutant melanoma 0.640167 sample size 0.421859	palliative radiation therapy 0.502761 multicenter trial 0.445549 temozolomide group 0.594959 multiagent chemotherapy 0.434715 randomized trial 0.479926 first-line vs. 0.432084 Clin Oncol 0.536064 Combination therapies 0.426982 genomic subtypes 0.583162 superior OS 0.42215 recent registration trials 0.531572 guide clinical decision-making 0.554726 Grob JJ 0.535846 High-dose recombinant interleukin 0.518234 ECOG PS 0.423492 randomised phase 0.46148 metastatic melanoma 0.981501 previously untreated patients 0.74564 primary endpoints 0.427198 metastatic malignant melanoma 0.829145 stage IV melanoma 0.540818 U.S. Food 0.438775	CLICK HERE
1510	National Cancer Institute	Html	en	Small Cell Lung Cancer Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of small cell lung cancer.	Lung Cancer Cooperative 0.39126 small-cell lung cancer 0.985475 European Lung Cancer 0.390681 chemotherapy 0.385408 Engl J Med 0.425383 American Cancer Society 0.349857 Br J Cancer 0.382857 limited-stage small-cell lung 0.52446 Lung cancer deaths 0.390773 tobacco-specific lung carcinogen 0.37583 Lung Oncology Group 0.359221 Radiat Oncol Biol 0.383871 Lung Cancer Group 0.384497 oncology group study 0.36864 poor-prognosis small-cell lung 0.365771 Natl Cancer Inst 0.372388 cancer research campaign 0.352725 Council Lung Cancer 0.415558 stage small-cell lung 0.379153 Medical Research Council 0.386248 small-cell lung carcinoma 0.374311 et al. 0.448513 Lung Cancer Working 0.375734 extensive-disease small-cell lung 0.370168 Research Council Lung 0.400238	Cancer Epidemiol Biomarkers 0.349186 PUBMED Abstract 0.373095 limited-disease small-cell lung 0.382414 extensive small-cell lung 0.411565 limited-stage small cell 0.350265 small cell lung 0.655538 prophylactic cranial irradiation 0.394396 disease small-cell lung 0.396424 extensive-stage small-cell lung 0.398504 lung cancer patients 0.41432 Cancer Lung Cancer 0.412017 Abstract 0.488813 Clin Oncol 0.605439 cell lung carcinoma 0.379947 Oncol Biol Phys 0.385351 untreated small-cell lung 0.364584 lung cancer risk 0.385828 advanced small-cell lung 0.364607 Low-dose lung 0.356029 cell lung cancer 0.62237 better-prognosis small-cell lung 0.365507 multiple lung nodules 0.359952 thoracic radiotherapy 0.411609 limited small-cell lung 0.423802	CLICK HERE
1601	National Cancer Institute	Html	en	Genetics of Prostate Cancer (PDQ®)–Health Professional Version	People with certain gene mutations (variants) are at risk for inherited prostate cancer. Learn about the hereditary prostate cancer genes, genetic testing, clinical management, psychosocial issues, and genetic counseling in this expert-reviewed summary.	prostate cancer-susceptibility 0.494988 hereditary prostate cancer 0.646658 prostate cancer families 0.58011 high-risk prostate cancer 0.499108 prostate cancer age 0.510834 HPCX prostate cancer 0.495626 fide prostate cancer 0.50138 race-specific prostate cancer 0.517373 potential prostate cancer 0.502444 prostate cancer treatment 0.519074 Prostate cancer clusters 0.508795 Prostate Cancer Study 0.526793 prostate cancer incidence 0.518066 familial prostate cancer 0.542174 prostate cancer cells 0.504131 prostate cancer risk 0.754001 American prostate cancer 0.505185 prostate cancer patients 0.535381 subsequent prostate cancer 0.507929 non-hereditary prostate cancer 0.492275 prostate cancer–specific death 0.491479 prostate cancer aggressiveness 0.502657 prostate cancer severity 0.49742 prostate cancer locus 0.502621 early-onset prostate cancer. 0.497689	early-onset prostate cancer 0.53348 prostate cancer genetics 0.56365 Utah prostate cancer 0.495471 prostate cancer probands 0.507097 prostate cancer linkage 0.517426 prostate cancer Gleason 0.494782 cancer susceptibility genes 0.494497 prostate cancer cases 0.542257 prostate cancer susceptibility 0.699453 prostate cancer studies 0.519772 prostate cancer genes 0.510925 prostate cancer pedigrees 0.508751 incident prostate cancer 0.504028 sporadic prostate cancer 0.570825 prostate cancer gene 0.496588 prostate cancer diagnosis 0.510536 multiple-case prostate cancer 0.503665 michigan prostate cancer 0.512155 prostate cancer 0.936188 family history 0.509854 new prostate cancer 0.496227 prostate cancer. 0.520558 aggressive prostate cancer 0.511403 prostate cancer risk. 0.505722	CLICK HERE
1630	National Cancer Institute	Html	en	Aromatherapy and Essential Oils (PDQ®)–Health Professional Version	Aromatherapy with the use of essential oils has been studied in cancer patients to help with symptom relief. Read about how massage or inhalation of essential oils have reduced symptoms in cancer patients in this expert-reviewed summary.	aromatherapy community 0.523554 tea tree oil 0.469913 wound care 0.4653 United States 0.467607 carrier oil 0.505684 Essential Oil Therapeutics 0.474385 psychological effects 0.470941 different oils 0.473782 aromatherapy certification 0.522781 PUBMED Abstract 0.469015 Antibacterial essential oils 0.493066 bergamot inhalation aromatherapy 0.536518 specific term aromatherapy 0.536256 aromatherapy massage group 0.539266 essential oil 0.524 aromatherapy massage 0.663988 aromatherapy report 0.522799 term aromatherapy 0.542043 aromatherapy service 0.504027 patients 0.509871 cancer patients 0.473471 Aromatherapy products 0.521987 aromatherapy intervention 0.509122	inhaled aromatherapy 0.507794 tea tree oils 0.475361 bergamot essential oil 0.467339 literature discuss aromatherapy 0.521543 tree oil regimen 0.472853 aromatherapy literature 0.519173 aromatherapy uses 0.508338 effects 0.513376 Different aromatherapy practitioners 0.543887 tea tree 0.478483 aromatherapy 0.796005 international aromatherapy programs 0.535662 aromatherapy remedies 0.530036 ginger essential oil 0.475255 aromatherapy massage. 0.507361 essential oil inhalation 0.474597 lavender essential oil 0.470969 essential oils 0.95098 essential oils age 0.490389 adjunctive aromatherapy massage 0.53024 aromatherapy result 0.508296 weekly aromatherapy massage 0.530549 aromatherapy sessions 0.504333	CLICK HERE
1677	National Cancer Institute	Html	en	Childhood Astrocytomas Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of childhood astrocytomas.	pediatric low-grade gliomas 0.895421 tuberous sclerosis complex 0.221251 low-grade tumors 0.216076 Metastatic Low-Grade Gliomas 0.260825 Neuro Oncol 0.285791 low-grade glioma survivors 0.203358 PUBMED Abstract 0.35985 Pediatr Blood Cancer 0.763903 brain tumors 0.222722 children 0.324078 low-grade astrocytomas 0.305374 low-grade pediatric cerebellar 0.210061 optic pathway gliomas 0.312364 pediatric high-grade gliomas 0.220149 pediatric low-grade astrocytoma 0.249661 childhood low-grade glioma 0.299154 progressive low-grade gliomas 0.291794 diencephalic low-grade astrocytomas 0.277863	Int J Radiat 0.209928 Radiat Oncol Biol 0.379939 childhood low-grade astrocytomas 0.251238 Abstract 0.698357 pilocytic astrocytoma 0.38953 Clin Oncol 0.34194 Oncol Biol Phys 0.387239 pediatric pilocytic astrocytomas 0.34638 pilocytic astrocytomas 0.377237 low-grade gliomas 0.925641 cord low-grade gliomas 0.248696 tumors 0.242639 recurrent low-grade gliomas 0.279246 radiation therapy 0.261839 refractory low-grade gliomas 0.256503 pediatric gliomas 0.231368 et al. 0.71515 pediatric low-grade glioma 0.48802	CLICK HERE
2034	National Cancer Institute	Html	es	Exámenes de detección del cáncer de próstata (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca de los factores que pueden influir en el desarrollo del cáncer de próstata y sobre la investigación dirigida a la prevención de esta enfermedad.	Visuals Online 0.517288 hiperplasia prostática benigna 0.934751 PDQ Exámenes 0.558681 Physician Data Query 0.625171 Estados Unidos 0.627104 prevención revisa 0.522163 sistema urinario masculino 0.572586 PDQ Prevención 0.600306	largo plazo 0.529195 aparato reproductor masculino 0.57627 información ayuda 0.525906 National Cancer Institute 0.530649 semen.ampliar anatomía 0.542589 siguientes riesgos 0.520738 siguientes sumarios 0.573516 Instituto Nacional 0.558713	CLICK HERE
16694	National Cancer Institute	Html	en	Using Trusted Resources	Information to help people evaluate the source and credibility of health information that they find in print or online.	health information publications 0.57623 medical library 0.468332 health care provider 0.525342 health information 0.816796 reputable sources 0.472899 online cancer information 0.566643 research journal 0.468961 medical credentials 0.480401 Local bookstores 0.465602 web address 0.542919 Social media sites 0.525651 personal social media 0.523002 American Society 0.463271 official Facebook page 0.525821 online medical journal 0.526189 gather information 0.496052 Online health information 0.583998 trustworthy content 0.471688 credible source 0.478584 exact same kind 0.463002 educational institution 0.468599 different points 0.462708 health history 0.475507 evidence-based information 0.519837	sources 0.501557 research credentials 0.469047 Drug Administration 0.463656 book online 0.475614 different body 0.465806 health information online 0.591142 Twitter accounts 0.467298 National Cancer Institute 0.533494 alternative medicine 0.466042 social media 0.640507 Federal Trade Commission 0.517205 medical information 0.510795 Complementary therapies 0.46171 personal information 0.537771 new research results 0.519971 Cancer Treatment Scams 0.525934 book offer 0.46625 medical journals 0.535182 products online 0.470366 Government agencies 0.476589 social media accounts 0.610423 original source 0.543837 information 0.948691 good ways 0.467256	CLICK HERE